Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26FW46K
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,709
Award facts
- Contract value 100% obligated
- $38,708.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $38,708.83 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose in a 2-pen/mL formulation, with an ultimate completion date of February 5, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with parent company Cencora, Inc. (doing business as AmerisourceBergen) holding the overarching IDC vehicle.
The delivery will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility and supports the Defense Health Agency and military healthcare systems globally. Cosentyx is a biologic immunosuppressant used for treating autoimmune conditions, and this procurement falls within DLA's comprehensive pharmaceutical support program that supplies brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to military treatment facilities and veteran healthcare programs. The non-set-aside competitive award demonstrates AmerisourceBergen's established capability to meet federal procurement requirements for critical pharmaceutical commodities.
Quick answers
Who was awarded contract SPE2DR26FW46K?
SPE2DR26FW46K was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FW46K worth?
The government has obligated $38,709 on SPE2DR26FW46K.
Is contract SPE2DR26FW46K an order under another contract?
Yes. SPE2DR26FW46K is a delivery order under SPE2DR25D3011, an indefinite delivery contract.
Was contract SPE2DR26FW46K competed?
The extent of competition for SPE2DR26FW46K was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award